You are here: Home / Featured / U.S. Lawmakers Push Legislation to Boost Drug Pricing Transparency
U.S. Lawmakers Push Legislation to Boost Drug Pricing Transparency
Three U.S. legislators have introduced two bills aimed at boosting prescription drug pricing transparency.
The bills, the Patient Right to Know Drug Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), were introduced March 15 by Sens. Susan Collins, Claire McCaskill and Debbie Stabenow.
According to a Chain Drug Review report, the bills would bar "pharmacy gag clauses" which causes consumers to ultimately overpay for prescription drugs.
"Insurance is intended to save consumers money," Collins said in a statement. "Gag clauses in contracts that prohibit pharmacists from telling patients about the best prescription drug prices do the opposite."
To read the full report on Chain Drug Review, click here.
Article Covers Range of Opinions on Remdesivir Pricing 05/15/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Stanford Center for Health Education Launches Online Program… 08/11/2020